NIH Warns Data On Effectiveness Of Convalescent Plasma In Treating COVID-19 Is Weak
The National Institutes of Health has asked the Food and Drug Administration to delay allowing the use of convalescent plasma to treat COVID-19 because the proof of its effectiveness is weak.
Read more on NPR
The National Institutes of Health has asked the Food and Drug Administration to delay allowing the use of convalescent plasma to treat COVID-19 because the proof of its effectiveness is weak.
Read more on NPR
This is dummy text. It is not meant to be read. Accordingly, it is difficult to figure out when to end it. But then, this is dummy text. It is not meant to be read. Period.
Related Post
NPR News: Miami wants to become crypto's financial capital. New York's response? Bring it onMiami wants to become crypto's financial capital. New York's response? Bring it on
Miami and New Yo- NPR News: Biden to announce free COVID tests, more aid for hospitals to deal with omicronBiden to announce free COVID tests, more aid for hospitals to deal with omicron
The U.S. government
- NPR News: Schools embrace social and emotional learning to help 'overwhelmed' studentsSchools embrace social and emotional learning to help 'overwhelmed' students
School officials belie
- NPR News: COVID adds another layer of concern for Kentucky's tornado survivorsCOVID adds another layer of concern for Kentucky's tornado survivors
It was another difficult weeke
ConversionConversion EmoticonEmoticon